顔面注射は、クマの除去、眉毛の隆起、唇の薄化、頬骨の強化など、多くの用途で使用される顔の皮膚フィラーです。フェイシャルインジェクションは、老化、にきび、傷跡によって引き起こされるしわを減らし、肌の外観を滑らかにするためにも使用されます。主な適用領域は、ほうれい線、頬、唇、目の角などの顔と、手の背側領域の外観を向上させるためのものです。2023年、世界の顔面注射剤市場は88億6000万ドルと評価され、2029年には188億9000万ドルに達すると予想されます。
顔面注射は、美容医療市場で最も急速に成長しているセグメントの1つです。形成外科医とそのネットワークの増加により、顔面注射剤の必要性が高まっています。外科医を含む他の開業医も、食品医薬品局 (FDA) から、クリニックでの顔面注射剤の使用が承認されました。さらに、高齢者人口が増加し、合成カルシウムヒドロキシラプタイト (CaHA) フィラーなどの新しい顔面注射剤が利用可能になるにつれて、顔面注射剤市場は成長すると予測されます。その結果、この市場は予測期間中に拡大しました。顔面注射剤の需要の増加、リピーター、新しい適応症、地理的拡大、新しい応用分野の製品承認に関する政府の積極的な支援、および顔面注射剤業界での創造的なソリューションの商業化により、顔面注射剤企業間の合併、コラボレーション、パートナーシップ、および合意が推進されています。世界の顔面注射剤の市場価値は、2024年から2029年の予測期間中に12.60%のCAGRで成長すると予測されます。
目次
Table of Contents
1. Executive Summary
2. Introduction
2.1 Facial Injectables: An Overview
2.1.1 Advantages of Derma Fillers
2.2 Facial Injectables Segmentation: An Overview
2.2.1 Facial Injectables Segmentation
3. Global Market Analysis
3.1 Global Facial Injectables Market: An Analysis
3.1.1 Global Facial Injectables Market: An Overview
3.1.2 Global Facial Injectables Market by Value
3.1.3 Global Facial Injectables Market by Type (Derma Fillers and Neuromodulator Aesthetics)
3.1.4 Global Facial Injectables Market by Application (Facial Line Correction, Face Lift, Lip Treatment and Others)
3.1.5 Global Facial Injectables Market by End User (Hospitals and Medspa, Dermatology and Cosmetic Centers and Others)
3.1.6 Global Facial Injectables Market by Region (North America, Europe, Asia Pacific and Rest of the World)
3.2 Global Facial Injectables Market: Type Analysis
3.2.1 Global Facial Injectables Market by Type: An Overview
3.2.2 Global Derma Fillers Facial Injectables Market by Value
3.2.3 Global Derma Fillers Facial Injectables Market by Product (Hyaluronic Acid, Calcium Hydroxylapatite, Polylactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Fat Injection and Others)
3.2.4 Global Derma Fillers Facial Injectables Market Product by Value
3.2.5 Global Neuromodulator Aesthetics Facial Injectables Market by Value
3.3 Global Facial Injectables Market: Application Analysis
3.3.1 Global Facial Injectables Market by Application: An Overview
3.3.2 Global Facial Line Correction Treatment Injectables Market by Value
3.3.3 Global Face Lift Injectables Market by Value
3.3.4 Global Lip Treatment Injectables Market by Value
3.3.5 Global Other Facial Injectables Market by Value
3.4 Global Facial Injectables Market: End User Analysis
3.4.1 Global Facial Injectables Market by End User: An Overview
3.4.2 Global Hospitals and Medspa Facial Injectables Market by Value
3.4.3 Global Dermatology and Cosmetic Centers Facial Injectables Market by Value
3.4.4 Global Other End Users Facial Injectables Market by Value
4. Regional Market Analysis
4.1 North America Facial Injectables Market: An Analysis
4.1.1 North America Facial Injectables Market: An Overview
4.1.2 North America Facial Injectables Market by Value
4.1.3 North America Facial Injectables Market by Region (The US, Canada and Mexico)
4.1.4 The US Facial Injectables Market by Value
4.1.5 The US Facial Injectables Market by Type (Hyaluronic Acid, Calcium Hydroxylapatite, Polylactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), and Others)
4.1.6 The US Neuromodulator Aesthetics Facial Injectables Market by Value
4.1.7 The US Derma Fillers Facial Injectables Market by Value
4.1.8 The US Derma Fillers Facial Injectables Market Product by Value
4.1.9 Canada Facial Injectables Market by Value
4.1.10 Mexico Facial Injectables Market by Value
4.2 Europe Facial Injectables Market: An Analysis
4.2.1 Europe Facial Injectables Market: An Overview
4.2.2 Europe Facial Injectables Market by Value
4.2.3 Europe Facial Injectables Market by Type (Hyaluronic Acid, Calcium Hydroxylapatite, Polylactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Fat Injection and Others)
4.2.4 Europe Derma Fillers Facial Injectables Market by Value
4.2.5 Europe Derma Fillers Facial Injectables Market Product by Value
4.2.6 Europe Neuromodulator Aesthetics Facial Injectables Market by Value
4.2.7 Europe Facial Injectables Market by Region (Germany, France, UK, Italy, Spain and Rest of Europe)
4.2.8 Germany Facial Injectables Market by Value
4.2.9 France Facial Injectables Market by Value
4.2.10 UK Facial Injectables Market by Value
4.2.11 Italy Facial Injectables Market by Value
4.2.12 Spain Facial Injectables Market by Value
4.2.13 Rest of Europe Facial Injectables Market by Value
4.3 Asia Pacific Facial Injectables Market: An Analysis
4.3.1 Asia Pacific Facial Injectables Market: An Overview
4.3.2 Asia Pacific Facial Injectables Market by Value
4.3.3 Asia Pacific Facial Injectables Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific)
4.3.4 China Facial Injectables Market by Value
4.3.5 Japan Facial Injectables Market by Value
4.3.6 India Facial Injectables Market by Value
4.3.7 South Korea Facial Injectables Market by Value
4.3.8 Rest of Asia Pacific Facial Injectables Market by Value
4.4 Rest of the World Facial Injectables Market: An Analysis
4.4.1 Rest of the World Facial Injectables Market: An Overview
4.4.2 Rest of the World Facial Injectables Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Facial Injectables
5.1.2 Post COVID-19 Impact
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Geriatric Population
6.1.2 Amplified Disposable Income
6.1.3 Rising Social Media Influence
6.1.4 Growing Healthcare Expenditure
6.1.5 Increasing Beauty Consciousness among People
6.1.6 Shift In Consumer Preference For Minimally Invasive Procedures
6.2 Challenges
6.2.1 Adverse Effects Associated With Certain Facial Injectables
6.2.2 Stringent Regulators
6.2.3 Costly Treatments
6.3 Market Trends
6.3.1 New Product Launches
6.3.2 Increased Male Aesthetics
6.3.3 Younger Demographics Seeking Preventive Treatments
6.3.4 Artificial Intelligence (AI) and Digital Tools
6.3.5 Emerging Markets
6.3.6 Innovations
7. Competitive Landscape
7.1 The US Facial Injectables Market Players: Competitive Landscape
7.1.1 The US Neuromodulators Market Players: Competitive Landscape
7.1.2 The US Neuromodulators Facial Injectables Players by Market Share
7.1.3 The US Derma Fillers Market Players: Competitive Landscape
7.2 Europe Facial Injectables Market Players: Competitive Landscape
7.2.1 Europe Neuromodulators Market Players: Competitive Landscape
7.2.2 Europe Derma Fillers Market Players: Competitive Landscape
8. Company Profiles
8.1 AbbVie Inc. (Allergan Inc.)
8.1.1 Business Overview
8.1.2 Operating Regions
8.1.3 Business Strategy
8.2 Ipsen
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy
8.3 Revance Therapeutics, Inc.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy
8.4 Croma-Pharma GmbH
8.4.1 Business Overview
8.4.2 Operating Regions
8.4.3 Business Strategy
8.5 Merz Pharma GmbH & Co. KGaA
8.5.1 Business Overview
8.5.2 Business Strategy
8.6 Suneva Medical Inc.
8.6.1 Business Overview
8.6.2 Business Strategy
8.7 Medytox Inc.
8.7.1 Business Overview
8.7.2 Business Strategy
8.8 Sinclair Pharma Plc
8.8.1 Business Overview
8.8.2 Business Strategy
8.9 Galderma S.A.
8.9.1 Business Overview
8.9.2 Business Strategy
8.10 Evolus, Inc.
8.10.1 Business Overview
8.10.2 Business Strategy
8.11 Prollenium Medical Technologies Inc.
8.11.1 Business Overview
List of Figures
Figure 1: Advantages of Derma Fillers
Figure 2: Facial Injectables Segmentation
Figure 3: Global Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 4: Global Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 5: Global Facial Injectables Market by Type; 2023 (Percentage, %)
Figure 6: Global Facial Injectables Market by Application; 2023 (Percentage, %)
Figure 7: Global Facial Injectables Market by End User; 2023 (Percentage, %)
Figure 8: Global Facial Injectables Market by Region; 2023 (Percentage, %)
Figure 9: Global Derma Fillers Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 10: Global Derma Fillers Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 11: Global Derma Fillers Facial Injectables Market by Product; 2023 (Percentage, %)
Figure 12: Global Derma Fillers Facial Injectables Market Product by Value; 2019-2023 (US$ Million)
Figure 13: Global Derma Fillers Facial Injectables Market Product by Value; 2024-2029 (US$ Million)
Figure 14: Global Neuromodulator Aesthetics Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 15: Global Neuromodulator Aesthetics Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 16: Global Facial Line Correction Treatment Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 17: Global Facial Line Correction Treatment Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 18: Global Face Lift Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 19: Global Face Lift Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 20: Global Lip Treatment Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 21: Global Lip Treatment Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 22: Global Other Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 23: Global Other Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 24: Global Hospitals and Medspa Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 25: Global Hospitals and Medspa Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 26: Global Dermatology and Cosmetic Centers Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 27: Global Dermatology and Cosmetic Centers Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 28: Global Other End Users Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 29: Global Other End Users Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 30: North America Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 31: North America Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 32: North America Facial Injectables Market by Region; 2023 (Percentage, %)
Figure 33: The US Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 34: The US Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 35: The US Facial Injectables Market by Type; 2023 (Percentage, %)
Figure 36: The US Neuromodulator Aesthetics Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 37: The US Neuromodulator Aesthetics Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 38: The US Derma Fillers Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 39: The US Derma Fillers Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 40: The US Derma Fillers Facial Injectables Market Product by Value; 2019-2023 (US$ Million)
Figure 41: The US Derma Fillers Facial Injectables Market Product by Value; 2024-2029 (US$ Million)
Figure 42: Canada Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 43: Canada Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 44: Mexico Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 45: Mexico Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 46: Europe Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 47: Europe Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 48: Europe Facial Injectables Market by Type; 2023 (Percentage, %)
Figure 49: Europe Derma Fillers Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 50: Europe Derma Fillers Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 51: Europe Derma Fillers Facial Injectables Market Product by Value; 2019-2023 (US$ Million)
Figure 52: Europe Derma Fillers Facial Injectables Market Product by Value; 2024-2029 (US$ Million)
Figure 53: Europe Neuromodulator Aesthetics Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 54: Europe Neuromodulator Aesthetics Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 55: Europe Facial Injectables Market by Region; 2023 (Percentage, %)
Figure 56: Germany Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 57: Germany Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 58: France Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 59: France Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 60: UK Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 61: UK Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 62: Italy Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 63: Italy Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 64: Spain Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 65: Spain Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 66: Rest of Europe Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 67: Rest of Europe Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 68: Asia Pacific Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 69: Asia Pacific Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 70: Asia Pacific Facial Injectables Market by Region; 2023 (Percentage, %)
Figure 71: China Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 72: China Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 73: Japan Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 74: Japan Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 75: India Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 76: India Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 77: South Korea Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 78: South Korea Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 79: Rest of Asia Pacific Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 80: Rest of Asia Pacific Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 81: Rest of the World Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 82: Rest of the World Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 83: Global Percentage of Population Aged 65 or Over; 2022, 2023 and 2050 (Percentage, %)
Figure 84: Global GDP per Capita; 2019-2024 (US$ Thousand)
Figure 85: Global Number of Social Media Users; 2018-2028 (Billion)
Figure 86: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2023 (Percentage, %)
Figure 87: FDA Approved Toxins
Figure 88: The US Neuromodulators Facial Injectables Players by Market Share; 2023 (Percentage, %)
Figure 89: 6+ Approved Fillers in the US
Figure 90: Six Approved Toxins in European Countries
Figure 91: 10+ Approved Fillers in European Countries
Figure 92: AbbVie Inc. Revenue by Regions; 2023 (Percentage, %)
Figure 93: Ipsen Sales by Region; 2023 (Percentage, %)
Figure 94: Revance Therapeutics, Inc. Revenue by Segment; 2023 (Percentage, %)
Figure 95: Croma-Pharma GmbH Revenue by Regions; 2023 (Percentage, %)
